LENSAR (LNSR) Competitors $12.95 +0.02 (+0.15%) As of 10:54 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock LNSR vs. BBNX, EMBC, SMLR, CBLL, KIDS, AVNS, BVS, AXGN, BFLY, and DCTHShould you be buying LENSAR stock or one of its competitors? The main competitors of LENSAR include Beta Bionics (BBNX), Embecta (EMBC), Semler Scientific (SMLR), CeriBell (CBLL), OrthoPediatrics (KIDS), AVANOS MEDICAL (AVNS), Bioventus (BVS), AxoGen (AXGN), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. LENSAR vs. Its Competitors Beta Bionics Embecta Semler Scientific CeriBell OrthoPediatrics AVANOS MEDICAL Bioventus AxoGen Butterfly Network Delcath Systems LENSAR (NASDAQ:LNSR) and Beta Bionics (NASDAQ:BBNX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment. Do analysts prefer LNSR or BBNX? LENSAR presently has a consensus target price of $15.00, indicating a potential upside of 15.83%. Beta Bionics has a consensus target price of $23.44, indicating a potential upside of 62.92%. Given Beta Bionics' stronger consensus rating and higher possible upside, analysts clearly believe Beta Bionics is more favorable than LENSAR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LENSAR 0 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Beta Bionics 0 Sell rating(s) 4 Hold rating(s) 7 Buy rating(s) 1 Strong Buy rating(s) 2.75 Does the media refer more to LNSR or BBNX? In the previous week, Beta Bionics had 5 more articles in the media than LENSAR. MarketBeat recorded 7 mentions for Beta Bionics and 2 mentions for LENSAR. LENSAR's average media sentiment score of 1.87 beat Beta Bionics' score of 0.86 indicating that LENSAR is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LENSAR 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Beta Bionics 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do institutionals & insiders have more ownership in LNSR or BBNX? 40.2% of LENSAR shares are owned by institutional investors. 38.5% of LENSAR shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has higher earnings and valuation, LNSR or BBNX? LENSAR has higher earnings, but lower revenue than Beta Bionics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLENSAR$53.49M2.85-$31.40M-$4.85-2.67Beta Bionics$65.12M9.58-$54.76MN/AN/A Is LNSR or BBNX more profitable? Beta Bionics has a net margin of 0.00% compared to LENSAR's net margin of -99.17%. Beta Bionics' return on equity of 0.00% beat LENSAR's return on equity.Company Net Margins Return on Equity Return on Assets LENSAR-99.17% -737.30% -81.69% Beta Bionics N/A N/A N/A SummaryBeta Bionics beats LENSAR on 10 of the 14 factors compared between the two stocks. Get LENSAR News Delivered to You Automatically Sign up to receive the latest news and ratings for LNSR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LNSR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LNSR vs. The Competition Export to ExcelMetricLENSARMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$152.68M$6.94B$5.71B$9.50BDividend YieldN/A1.28%4.60%3.99%P/E Ratio-2.6725.4927.8819.97Price / Sales2.8550.80452.35101.58Price / CashN/A20.6736.5558.97Price / Book30.834.718.635.89Net Income-$31.40M$176.14M$3.24B$258.50M7 Day Performance-1.15%2.63%3.90%2.07%1 Month Performance3.60%3.11%10.47%12.39%1 Year Performance141.15%8.61%34.29%19.25% LENSAR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LNSRLENSAR1.3651 of 5 stars$12.95+0.2%$15.00+15.8%+149.1%$152.68M$53.49M-2.67110Positive NewsBBNXBeta BionicsN/A$14.30+5.2%$23.44+63.9%N/A$589.21M$65.12M0.00294News CoverageLockup ExpirationEMBCEmbecta4.6843 of 5 stars$10.29+5.2%$19.00+84.6%-30.4%$571.57M$1.12B11.432,100SMLRSemler Scientific2.6432 of 5 stars$39.67-3.8%$89.00+124.4%+18.1%$568.63M$56.29M-15.20120CBLLCeriBell2.3806 of 5 stars$15.21-2.4%$32.14+111.3%N/A$563.11M$65.44M0.00N/AKIDSOrthoPediatrics4.194 of 5 stars$21.88-0.6%$35.83+63.8%-32.8%$534.56M$212.45M-12.50200AVNSAVANOS MEDICAL2.9456 of 5 stars$11.40+1.6%N/A-47.3%$518.86M$687.80M-1.362,227News CoverageUpcoming EarningsBVSBioventus3.3652 of 5 stars$6.30+0.6%$13.75+118.3%-14.2%$517.51M$567.70M-10.331,200AXGNAxoGen2.2863 of 5 stars$11.61+2.9%$24.50+111.0%+42.5%$513.74M$194.52M-77.39450BFLYButterfly Network2.5547 of 5 stars$1.89+0.8%$3.50+85.7%+93.1%$462.43M$82.06M-6.50460News CoverageUpcoming EarningsDCTHDelcath Systems2.6412 of 5 stars$11.32+0.6%$24.00+112.0%+29.0%$391.80M$37.21M-22.6460 Related Companies and Tools Related Companies Beta Bionics Competitors Embecta Competitors Semler Scientific Competitors CeriBell Competitors OrthoPediatrics Competitors AVANOS MEDICAL Competitors Bioventus Competitors AxoGen Competitors Butterfly Network Competitors Delcath Systems Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LNSR) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENSAR, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENSAR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
